# EDGAR Filing Document

**Accession Number:** 0001756770
**File Stem:** 0001756770-26-000034
**Filing Date:** 2026-5
**Character Count:** 7138
**Document Hash:** 6b140148d42396c63acf9a806799bee8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001756770-26-000034.hdr.sgml**: 20260505

**ACCESSION NUMBER**: 0001756770-26-000034

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 4

**CONFORMED PERIOD OF REPORT**: 20260430

**FILED AS OF DATE**: 20260505

**DATE AS OF CHANGE**: 20260505

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Curaleaf Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001756770
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-249081
- **FILM NUMBER:** 26941824

**BUSINESS ADDRESS:**
- **STREET 1:** 420 LEXINGTON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10170
- **BUSINESS PHONE:** 781-451-0117

**MAIL ADDRESS:**
- **STREET 1:** 420 LEXINGTON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10170

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LEAD VENTURES INC.
- **DATE OF NAME CHANGE:** 20181023

**UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION <br>Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER <br>THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of April, 2026**

**Commission File Number: 333-249081**

**<u>Curaleaf Holdings, Inc.</u>**<br> (Name of Registrant)

**666 Burrard Street, Suite 1700,** 

**Vancouver, British Columbia V6C 2X8, Canada**<br>(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☐&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F ☒

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | **CURALEAF HOLDINGS, INC.** | **CURALEAF HOLDINGS, INC.** |
| | | (Registrant) | (Registrant) |
| Date: | April 30, 2026 | By: | */s/ Peter Clateman* |
|  |  | Name: | Peter Clateman |
|  |  | Title: | Chief Legal Officer |

---

------

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| [99.1](a2026-04x30xcuraleafxann.htm) | [Press Release](a2026-04x30xcuraleafxann.htm) |

---

## Exhibit 99.1

![](a2026-04x30xcuraleafxann001.jpg)

Curaleaf Holdings, Inc. Investor Relations Curaleaf Announces Date of Annual and Special Shareholders Meeting STAMFORD, Conn., April 30, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announces that the Annual and Special Meeting of its shareholders (the "Meeting") will be held on Monday, June 22, 2026, at 9:00 a.m. (Eastern time) in a virtual format. At the Meeting, shareholders will be asked: to approve the election as directors of the Company for the forthcoming year of the nominees proposed for election by the Company that will be listed in the management information circular to be mailed in connection with the Meeting; to approve the appointment of the auditors of the Company and to authorize the board of directors of the Company (the "Board") to fix the auditors' remuneration and the terms of their engagement; to pass an ordinary resolution to approve the continued ability of the Company to issue awards under the Company's 2018 Stock and Incentive Plan, as amended (the "LTIP"), including the unallocated awards thereunder; to pass a special resolution to approve an amendment to the Company's multiple voting shares, or MVS (controlled by its CEO and Chairman, Boris Jordan) to eliminate MVS sunset within one year after a U.S. stock exchange listing of its subordinate voting shares, while retaining the other existing MVS sunsets (the "Proposed Amendment"); to pass an ordinary resolution to approve the exchange of outstanding stock options having an exercise price or subject to performance vesting conditions tied to a trading price per share equal to or exceeding US$5.00 for new restricted share units issued under the LTIP (the "Option/RSU Exchange") and the participation of certain insiders of the Company in such Option/RSU Exchange; and to pass a special resolution to approve the previously announced plan of arrangement (the "Arrangement") to continue the Company from British Columbia to Delaware, as more particularly described in the press release of the Company dated January 7, 2026. The Board (other than Mr. Boris Jordan in respect of the Proposed Amendment) recommends that shareholders of the Company vote in favour of each of the above-described matters at the Meeting. Management Information Circular Details regarding the Meeting, the Proposed Amendment, the Option/RSU Exchange, the Arrangement, as well as the other matters to be considered by the shareholders of the Company at the Meeting, will be set out in a management information circular to be mailed in connection with the Meeting, which will be filed under the Company's profile on SEDAR+ at www.sedarplus.ca and under the Company's profile on EDGAR at sec.gov on or about May 12, 2026. Shareholders are encouraged to read the management information circular in its entirety and other relevant materials when they become available. Shareholders of the Company as at the close of business on Tuesday, May 5, 2026, will be entitled to receive notice of, and to vote at, the Meeting. Notice-and-Access The Company has decided to use the notice-and-access method to deliver the management information circular and other meeting materials for the Meeting (the "Meeting Materials") to both non-registered holders and registered shareholders. The notice-and-access mechanism allows the Company to deliver the Meeting Materials over the Internet in accordance with the notice-and-access rules adopted by the Canadian Securities Administrators under National Instrument 54-101 - Communication with Beneficial Owners of Securities of a Reporting Issuer. Under the notice-and-access system, registered shareholders will receive a form of proxy and non-registered holders will receive a voting instruction form enabling them to vote at the Meeting. However, instead of a paper copy of the Meeting Materials, shareholders will receive a notification with information on how they may access such materials electronically. The use of this alternative means of delivery is more environmentally friendly as it will help reduce paper use and will also reduce the printing and mailing costs of the Meeting Materials. Shareholders are reminded to review carefully the Meeting Materials prior to voting. About Curaleaf Holdings Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis

------

![](a2026-04x30xcuraleafxann002.jpg)

------